Art Advanced Research Technologies Incorporated - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Art Advanced Research Technologies Incorporated. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Art Advanced Research Technologies Incorporated. The Group's principal activities are to design, develop and market optical molecular imaging products for the healthcare and pharmaceutical industries. It has developed two products based on its innovative technology. The Group operates two segments: Pharmaceutical and Medical. The first is explore OptixTM, a molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs. The second is SoftScan(R), a medical imaging device designed to improve the diagnosis and treatment of breast cancer. The Group commercializes its products in a global strategic alliance with GE Healthcare.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report